Barclays’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3,700
| Closed | -$206K | – | 7628 |
|
|
2018
Q4 | $206K | Hold |
3,700
| – | – | ﹤0.01% | 4554 |
|
|
2018
Q3 | $172K | Sell |
3,700
-100
| -3% | -$4.84K | ﹤0.01% | 5134 |
|
|
2018
Q2 | $183K | Sell |
3,800
-500
| -12% | -$23.9K | ﹤0.01% | 4800 |
|
|
2018
Q1 | $186K | Sell |
4,300
-2,100
| -33% | -$94.3K | ﹤0.01% | 4892 |
|
|
2017
Q4 | $254K | Sell |
6,400
-400
| -6% | -$16.7K | ﹤0.01% | 4482 |
|
|
2017
Q3 | $295K | Sell |
6,800
-200
| -3% | -$9.13K | ﹤0.01% | 4101 |
|
|
2017
Q2 | $335K | Buy |
7,000
+6,900
| +6,900% | +$322K | ﹤0.01% | 3895 |
|
|
2017
Q1 | $4K | Buy |
+100
| New | +$4.17K | ﹤0.01% | 6362 |
|
|
2016
Q4 | – | Sell |
-545,000
| Closed | -$29.3M | – | 6993 |
|
|
2016
Q3 | $29.3M | Buy |
+545,000
| New | +$25.3M | 0.03% | 406 |
|
|
2014
Q3 | – | Sell |
-190,700
| Closed | -$4.96M | – | 7929 |
|
|
2014
Q2 | $4.96M | Buy |
+190,700
| New | +$4.92M | 0.01% | 1754 |
|
Barclays's IMPV Position: Q1 2019 in Review
Barclays sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 145 shares — an estimated $8K sold.
Barclays first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $933K in Q2 2014. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.
- Barclays reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
- Barclays sold 145 Imperva, Inc. shares in Q1 2019, an estimated $8K.
- Barclays first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
- Barclays's Imperva, Inc. position peaked at $933K in Q2 2014.
- 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.
Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.